-
1
-
-
18844417688
-
A definition of Parkinson's disease
-
DOI 10.1016/j.parkreldis.2005.01.008, PII S1353802005000404
-
D Calne 2005 A definition of Parkinson's disease Parkinsonism Relat Disord 11 S39 S40 10.1016/j.parkreldis.2005.01.008 15885627 (Pubitemid 40693576)
-
(2005)
Parkinsonism and Related Disorders
, vol.11
, Issue.SUPPL. 1
-
-
Calne, D.1
-
2
-
-
5744233877
-
Brain-derived neurotrophic factor
-
DOI 10.1080/08977190410001723308
-
DK Binder HE Scharfman 2004 Brain-derived neurotrophic factor Growth Factors 22 123 131 10.1080/08977190410001723308 1:CAS:528:DC%2BD2cXpt1alu7c%3D 15518235 (Pubitemid 39377904)
-
(2004)
Growth Factors
, vol.22
, Issue.3
, pp. 123-131
-
-
Binder, D.K.1
Scharfman, H.E.2
-
3
-
-
37849050242
-
Neurotrophic factors in Alzheimer's disease: Role of axonal transport
-
1:CAS:528:DC%2BD1cXivVyhsrs%3D 18184369
-
K Schindowski K Belarbi L Buée 2008 Neurotrophic factors in Alzheimer's disease: role of axonal transport Genes Brain Behav 7 43 56 1:CAS:528:DC%2BD1cXivVyhsrs%3D 18184369
-
(2008)
Genes Brain Behav
, vol.7
, pp. 43-56
-
-
Schindowski, K.1
Belarbi, K.2
Buée, L.3
-
4
-
-
34250867453
-
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients
-
DOI 10.1002/ajmg.b.30501
-
A Ciammola J Sassone M Cannella, et al. 2007 Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients Am J Med Genet B Neuropsychiatr Genet 144B 574 577 10.1002/ajmg.b.30501 1:CAS:528:DC%2BD2sXnsVSlu7s%3D 17427191 (Pubitemid 46983172)
-
(2007)
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
, vol.144
, Issue.4
, pp. 574-577
-
-
Ciammola, A.1
Sassone, J.2
Cannella, M.3
Calza, S.4
Poletti, B.5
Frati, L.6
Squitieri, F.7
Silani, V.8
-
5
-
-
0033762265
-
Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra
-
10.1006/exnr.2000.7483 1:CAS:528:DC%2BD3cXnt1WjsLk%3D 11031089
-
DW Howells MJ Porritt JYF Wong, et al. 2000 Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra Exp Neurol 166 127 135 10.1006/exnr.2000.7483 1:CAS:528:DC%2BD3cXnt1WjsLk%3D 11031089
-
(2000)
Exp Neurol
, vol.166
, pp. 127-135
-
-
Howells, D.W.1
Porritt, M.J.2
Wong, J.Y.F.3
-
6
-
-
0033602009
-
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra
-
K Parain MG Murer Y Quiao, et al. 1999 Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra Neuroreport 10 557 561 10.1097/00001756-199902250-00021 1:STN:280:DyaK1M3itlarug%3D%3D 10208589 (Pubitemid 29333282)
-
(1999)
NeuroReport
, vol.10
, Issue.3
, pp. 557-561
-
-
Parain, K.1
Murer, M.G.2
Yan, Q.3
Faucheux, B.4
Agid, Y.5
Hirsch, E.6
Raisman-Vozari, R.7
-
7
-
-
0033597983
-
Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease
-
DOI 10.1016/S0304-3940(99)00463-2, PII S0304394099004632
-
M Mogi A Togaria T Kondo, et al. 1999 Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease Neurosci Lett 270 45 48 10.1016/S0304-3940(99)00463-2 1:CAS:528:DyaK1MXksFait74%3D 10454142 (Pubitemid 29322994)
-
(1999)
Neuroscience Letters
, vol.270
, Issue.1
, pp. 45-48
-
-
Mogi, M.1
Togari, A.2
Kondo, T.3
Mizuno, Y.4
Komure, O.5
Kuno, S.6
Ichinose, H.7
Nagatsu, T.8
-
8
-
-
0036092437
-
Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra
-
DOI 10.1016/S1353-8020(02)00008-1, PII S1353802002000081
-
C Knott G Stern A Kingsbury 2002 Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra Parkinsonism Relat Disord 8 329 341 10.1016/S1353-8020(02)00008-1 1:STN:280:DC%2BD2c3nvFemsw%3D%3D 15177062 (Pubitemid 34518414)
-
(2002)
Parkinsonism and Related Disorders
, vol.8
, Issue.5
, pp. 329-341
-
-
Knott, C.1
Stern, G.2
Kingsbury, A.3
Welcher, A.A.4
Wilkin, G.P.5
-
9
-
-
27944457221
-
The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: A meta-analysis
-
DOI 10.1007/s10038-005-0295-z
-
E Zintzaras GM Hadjigeorgiou 2005 The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis J Hum Genet 50 560 566 10.1007/s10038-005-0295-z 1:CAS:528:DC%2BD2MXht1enu7zF 16172806 (Pubitemid 41666975)
-
(2005)
Journal of Human Genetics
, vol.50
, Issue.11
, pp. 560-566
-
-
Zintzaras, E.1
Hadjigeorgiou, G.M.2
-
10
-
-
0029610630
-
Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease
-
M Levivier S Przedborski C Bencsics UJ Kang 1995 lntrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease J Neurosci 15 7810 7820 1:CAS:528:DyaK28Xls1Cl 8613721 (Pubitemid 26006890)
-
(1995)
Journal of Neuroscience
, vol.15
, Issue.12
, pp. 7810-7820
-
-
Levivier, M.1
Przedborski, S.2
Bencsics, C.3
Kang, U.J.4
-
11
-
-
38449122713
-
Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons
-
10.1007/BF03033922 1:CAS:528:DC%2BD2sXhtlKiu7fO 17967737
-
I Mocchetti A Bachis RL Nosheny G Tanda 2007 Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons Neurotox Res 12 135 143 10.1007/BF03033922 1:CAS:528:DC%2BD2sXhtlKiu7fO 17967737
-
(2007)
Neurotox Res
, vol.12
, pp. 135-143
-
-
Mocchetti, I.1
Bachis, A.2
Nosheny, R.L.3
Tanda, G.4
-
12
-
-
34248215035
-
Measurements of brain-derived neurotrophic factor: Methodological aspects and demographical data
-
DOI 10.1016/j.brainresbull.2007.03.009, PII S0361923007001049
-
V Trajkovska AB Marcussen M Vinberg, et al. 2007 Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data Brain Res Bull 73 143 149 10.1016/j.brainresbull.2007.03.009 1:CAS:528:DC%2BD2sXlt1aju7s%3D 17499648 (Pubitemid 46722657)
-
(2007)
Brain Research Bulletin
, vol.73
, Issue.1-3
, pp. 143-149
-
-
Trajkovska, V.1
Marcussen, A.B.2
Vinberg, M.3
Hartvig, P.4
Aznar, S.5
Knudsen, G.M.6
-
15
-
-
45849098660
-
The accuracy of diagnosis of major depression in patients with Parkinson's disease: A comparative study among the UPDRS, the geriatric depression scale and the Beck Depression Inventory
-
DOI 10.1590/S0004-282X2008000200002
-
V Tumas GGR Rodrigues TLA Farias JAS Crippa 2008 The accuracy of diagnosis of major depression in patients with Parkinson's disease: A comparative study among the UPDRS, the Geriatric Depression Scale and the Beck Depression Inventory Arq Neuropsiquiatr 66 152 156 18545773 (Pubitemid 351883892)
-
(2008)
Arquivos de Neuro-Psiquiatria
, vol.66
, Issue.A2
, pp. 152-156
-
-
Tumas, V.1
Rodrigues, G.G.R.2
Farias, T.L.A.3
Crippa, J.A.S.4
-
16
-
-
0000224448
-
Unified Parkinson's disease rating scale
-
Fahn S, Marsden CD, Caine DB, Goldstein M, (eds) Macmillan Health Care information, Florham Park 293-304
-
Fahn S, Elton R (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Caine DB, Goldstein M, (eds) Recent developments in Parkinson's disease, vol 2. Macmillan Health Care information, Florham Park, pp 153-163, 293-304
-
(1987)
Recent Developments in Parkinson's Disease
, vol.2
, pp. 153-163
-
-
Fahn, S.1
Elton, R.2
-
17
-
-
0014082977
-
Parkinsonism: Onset, progression and mortality
-
1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
-
MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
-
(1967)
Neurology
, vol.17
, pp. 427-442
-
-
Hoehn, M.M.1
Yahr, M.D.2
-
18
-
-
16844373270
-
Validating the Berg Balance Scale for patients with Parkinson's disease: A key to rehabilitation evaluation
-
DOI 10.1016/j.apmr.2004.11.005
-
AA Qutubuddin PO Pegg DX Cifu, et al. 2005 Validating the Berg Balance Scale for patients with Parkinson's disease: a key to rehabilitation evaluation Arch Phys Med Rehabil 86 789 792 10.1016/j.apmr.2004.11.005 15827933 (Pubitemid 40487848)
-
(2005)
Archives of Physical Medicine and Rehabilitation
, vol.86
, Issue.4
, pp. 789-792
-
-
Qutubuddin, A.A.1
Pegg, P.O.2
Cifu, D.X.3
Brown, R.4
McNamee, S.5
Carne, W.6
-
19
-
-
0026031194
-
The timed "up and Go": A test of basic functional mobility for frail elderly persons
-
1:STN:280:DyaK3M7itlKgsA%3D%3D 1991946
-
D Podsiadlo S Richardson 1991 The timed "Up and Go": a test of basic functional mobility for frail elderly persons J Am Geriatr Soc 39 142 148 1:STN:280:DyaK3M7itlKgsA%3D%3D 1991946
-
(1991)
J Am Geriatr Soc
, vol.39
, pp. 142-148
-
-
Podsiadlo, D.1
Richardson, S.2
-
20
-
-
0036255090
-
Reliability of gait speed measured by a timed walking test in patients one year after stroke
-
DOI 10.1191/0269215502cr495oa
-
J Green A Forster J Young 2002 Reliability of gait speed measured by a timed walking test in patients one year after stroke Clin Rehabil 16 306 314 10.1191/0269215502cr495oa 12017517 (Pubitemid 34467222)
-
(2002)
Clinical Rehabilitation
, vol.16
, Issue.3
, pp. 306-314
-
-
Green, J.1
Forster, A.2
Young, J.3
-
21
-
-
0036644465
-
ATS statement: Guidelines for the six minute walk test
-
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
-
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories 2002 ATS statement: guidelines for the six minute walk test Am J Resp Crit Care Med 166 111 117
-
(2002)
Am J Resp Crit Care Med
, vol.166
, pp. 111-117
-
-
-
22
-
-
21544446985
-
Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta
-
DOI 10.1523/JNEUROSCI.4601-04.2005
-
ZC Baquet PC Bickford KR Jones 2005 Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta J Neurosci 25 6251 6259 10.1523/JNEUROSCI. 4601-04.2005 1:CAS:528:DC%2BD2MXmtFKntb4%3D 15987955 (Pubitemid 40923492)
-
(2005)
Journal of Neuroscience
, vol.25
, Issue.26
, pp. 6251-6259
-
-
Baquet, Z.C.1
Bickford, P.C.2
Jones, K.R.3
-
23
-
-
13444273332
-
Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons
-
DOI 10.1016/j.expneurol.2004.11.030
-
MJ Porritt PE Batchelor DW Howells 2005 Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons Exp Neurol 192 226 234 10.1016/j.expneurol.2004.11.030 1:CAS:528: DC%2BD2MXhtVKgs7s%3D 15698637 (Pubitemid 40208556)
-
(2005)
Experimental Neurology
, vol.192
, Issue.1
, pp. 226-234
-
-
Porritt, M.J.1
Batchelor, P.E.2
Howells, D.W.3
-
24
-
-
33750049661
-
Serum BDNF, TNF-α and IL-1β levels in dementia patients: Comparison between Alzheimer's disease and vascular dementia
-
DOI 10.1007/s00406-006-0652-8
-
C Yasutake K Kuroda T Yanagawa, et al. 2006 Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia Eur Arch Psychiatry Clin Neurosci 256 402 406 10.1007/s00406-006-0652-8 16783499 (Pubitemid 44584054)
-
(2006)
European Archives of Psychiatry and Clinical Neuroscience
, vol.256
, Issue.7
, pp. 402-406
-
-
Yasutake, C.1
Kuroda, K.2
Yanagawa, T.3
Okamura, T.4
Yoneda, H.5
-
25
-
-
33747891466
-
Stage-dependent BDNF serum concentrations in Alzheimer's disease
-
DOI 10.1007/s00702-005-0397-y
-
C Laske E Stransky T Leyhe, et al. 2006 Stage-dependent BDNF serum concentrations in Alzheimer's disease J Neural Transm 113 1217 1224 10.1007/s00702-005-0397-y 1:CAS:528:DC%2BD28Xosleqsb4%3D 16362629 (Pubitemid 44291016)
-
(2006)
Journal of Neural Transmission
, vol.113
, Issue.9
, pp. 1217-1224
-
-
Laske, C.1
Stransky, E.2
Leyhe, T.3
Eschweiler, G.W.4
Wittorf, A.5
Richartz, E.6
Bartels, M.7
Buchkremer, G.8
Schott, K.9
-
26
-
-
34248663802
-
Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder
-
DOI 10.1016/j.neulet.2007.04.001, PII S0304394007004004
-
CS Gama AC Andreazza M Kunz, et al. 2007 Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder Neurosci Lett 420 45 48 10.1016/j.neulet.2007.04.001 1:CAS:528:DC%2BD2sXlvVyiurY%3D 17442489 (Pubitemid 46777098)
-
(2007)
Neuroscience Letters
, vol.420
, Issue.1
, pp. 45-48
-
-
Gama, C.S.1
Andreazza, A.C.2
Kunz, M.3
Berk, M.4
Belmonte-de-Abreu, P.S.5
Kapczinski, F.6
-
27
-
-
44649183920
-
Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia
-
10.1016/j.neulet.2008.05.022 1:CAS:528:DC%2BD1cXmvVKks7w%3D 18514407
-
HJ Reis R Nicolato IG Barbosa, et al. 2008 Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia Neurosci Lett 439 157 159 10.1016/j.neulet.2008.05.022 1:CAS:528:DC%2BD1cXmvVKks7w%3D 18514407
-
(2008)
Neurosci Lett
, vol.439
, pp. 157-159
-
-
Reis, H.J.1
Nicolato, R.2
Barbosa, I.G.3
-
28
-
-
33847254358
-
Brain derived neurotropic factor in first-episode psychosis
-
DOI 10.1016/j.schres.2006.12.026, PII S0920996407000357
-
PF Buckley A Pillai D Evans, et al. 2007 Brain derived neurotropic factor in first-episode psychosis Schizophr Res 91 1 5 10.1016/j.schres.2006.12.026 17306505 (Pubitemid 46320904) (Pubitemid 46320904)
-
(2007)
Schizophrenia Research
, vol.91
, Issue.1-3
, pp. 1-5
-
-
Buckley, P.F.1
Pillai, A.2
Evans, D.3
Stirewalt, E.4
Mahadik, S.5
-
29
-
-
0025515348
-
The relationship of negative schizophrenia to parkinsonism
-
10.3109/00207459008987178 1:STN:280:DyaK3M%2FnvV2hug%3D%3D 2147920
-
R Sandyk SR Kay 1990 The relationship of negative schizophrenia to parkinsonism Int J Neurosci 55 1 59 10.3109/00207459008987178 1:STN:280:DyaK3M%2FnvV2hug%3D%3D 2147920
-
(1990)
Int J Neurosci
, vol.55
, pp. 1-59
-
-
Sandyk, R.1
Kay, S.R.2
-
30
-
-
0028856570
-
Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients
-
1:STN:280:DyaK28%2FotVSjtA%3D%3D 8526237
-
A Chatterjee M Chakos A Koreen, et al. 1995 Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients Am J Psychiatry 152 1724 1729 1:STN:280: DyaK28%2FotVSjtA%3D%3D 8526237
-
(1995)
Am J Psychiatry
, vol.152
, pp. 1724-1729
-
-
Chatterjee, A.1
Chakos, M.2
Koreen, A.3
-
31
-
-
34248570313
-
Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease
-
T Yasuhara T Shingo I Date 2007 Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease Acta Med Okayama 61 51 56 1:CAS:528:DC%2BD2sXlsVSltb8%3D 17471304 (Pubitemid 46798852)
-
(2007)
Acta Medica Okayama
, vol.61
, Issue.2
, pp. 51-56
-
-
Yasuhara, T.1
Shingo, T.2
Date, I.3
|